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Background: Enhanced recovery after surgery (ERAS) reduces postoperative stress, increases 
patient satisfaction, and reduces postoperative stay and cost. In this study, we evaluated the 
feasibility and effectiveness of ERAS protocols compared with conventional perioperative care 
group and their effect in gastric cancer patients undergoing gastrectomy.
Methods: A cohort of 366 patients were analyzed from a prospectively maintained database. 
The patients’ characteristics, tumor profile, surgical information data and postoperative com-
plications were evaluated.
Results: Patients in the ERAS had a faster gastrointestinal function recovery and first flatus 
(3.26±0.64; P<0.001). Pain intensity of patients in the ERAS group was significantly lower than 
that of patients in the conventional care group on postoperative days 1 (2.33±0.98; P<0.001) 
and 3 (1.06±0.63; P<0.001). Postoperative hospital stays were significantly shorter in patients 
receiving ERAS program (6.66±3.36; P<0.001), than in those patients who received conventional 
perioperative care (9.02±2.61).
Conclusion: ERAS can reduce postoperative stress, enhance the recovery of the gut, reduce the 
pain intensity, and increase satisfaction in gastric cancer patient undergoing curative gastrectomy.
Keywords: enhanced recovery after surgery, postoperative stress, pain intensity, postoperative 
complications, gastric cancer
Introduction
Enhanced recovery after surgery (ERAS) was implemented by Wilmore and Kehlet in 
the mid-1990s.1 Its multidisciplinary interventions aim to attenuate the surgical stress 
response and organ dysfunction, thereby enhancing recovery of intestinal mobility 
and accelerating full recovery, reducing the morbidity associated with postoperative 
complications, minimizing the length of postoperative hospitalization and reducing 
health care costs, all without compromising patient safety and ultimately leading to 
patients’ satisfaction.2
In recent years, ERAS has been successfully implemented in several surgical diseases, 
such as colorectal surgery.3 Previous prospective and retrospective studies have proven the 
feasibility of ERAS protocols in gastrectomy patients.2,4 Gastric cancer (GC) is among 
the most common cancers worldwide, especially in China, and the second leading cause 
of cancer-related death.5 Approximately 400,000 cases of GC are diagnosed in China 
annually.6 A radical gastrectomy with D2 lymphadenectomy is the most appropriate 
treatment of GC. However, gastric cancer surgery is a complicated surgery that has high 
risk and is associated with postoperative stress, complications, and sequelae.
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The rates of postoperative morbidity and mortality after 
conventional radical gastrectomy and perioperative care 
range from 10% to 46% and 0.8% to 10%, respectively.7 
Postoperative complications such as anastomotic leakage, 
pulmonary disease, pancreatitis, digestive fistulas, internal 
bleeding, and bowel obstruction prolong the duration of 
hospital stays and increase the hospital costs.7 The aim of the 
present study was to evaluate the feasibility and effectiveness 
of our ERAS protocols compared with gastric cancer patients 
with conventional perioperative care undergoing gastrectomy.
Methods
Patients
Some 366 patients with gastric cancer who underwent gas-
trectomy with a curative intent at the Department of Gastro-
intestinal Surgery, Changhai Hospital affiliated to the Second 
Military Medical University from January 2011 to April 2014 
were enrolled in the study. The conventional patients were 
added from a well-maintained retrospective database, whereas 
the ERAS group was prospectively enrolled. The Ethics 
Committee of the Changhai Hospital of the Second Military 
Medical University approved this study. Only one team with 
a standard surgical principle performed all surgeries.
study criteria
The inclusion criteria were as follows: 1) diagnosis of gastric 
adenocarcinoma confirmed by a preoperative gastroscopy 
and pathological biopsy and 2) curative gastrectomy without 
simultaneous resection of other organs. Patients with preop-
erative complete digestive tract obstruction or digestive tract 
perforation were not included in this study. Clinical staging 
was determined according to the American Joint Commit-
tee on Cancer 7th edition – TNM (tumor, node, metastasis) 
staging of I–III for postoperative pathological diagnosis. 
Written informed consent was obtained from the patient and 
the family to receive perioperative care.
Data collection
All data were retrieved from the patients’ database and 
clinical records. The items studied were the patients’ char-
acteristics, tumor profile, surgical information, postoperative 
data and postoperative complications. Patient characteristics 
evaluated includes age, gender, body mass index (BMI), 
Nutritional Risk Screening (NRS) 2002 score, and the risk 
grade of the American Society of Anesthesiologists (ASA) 
score. The tumor profile included the pathological T and N 
factors and pathological tumor stage (TNM classification). 
Surgical-related data included the kind of procedure and 
the type of reconstruction, operation time and intraopera-
tive blood loss. Postoperative data included the time of the 
first flatus or defecation, maximum pain on a visual analog 
scale (VAS, evaluated at postoperative day [POD] 1 and 3), 
the number of additional doses of analgesics, postoperative 
hospital stays, 30-day readmission. The recovery of bowel 
function was evaluated by the time of first flatus. Blood 
samples were collected 1 day before surgery and POD 1 and 
3. Postoperative complications, 30-day readmissions and 
mortality were used to assess the safety of ERAS.
eRas program
The ERAS program can be divided into preoperative, intra-
operative and postoperative phases. Detailed information 
about the treatment and perioperative care was explained to 
the patients on admission.8,9 Patients could eat a normal diet 
until midnight of the day before surgery and were allowed 
to drink up to 500 mL of a carbohydrate-rich drink (18.0 g 
carbohydrate per 100 mL) until 4 hours before surgery. There 
was no bowel and nasogastric tube decompression.10 The body 
temperature was strictly monitored and kept above 36°C. 
Anesthesia consisted a combination of general anesthesia 
and local preemptive analgesia. Surgical incisions sites were 
pre- and postoperatively injected with 0.25% bupivacaine 
hydrochloride solution. Intraoperatively, the fluid therapy was 
closely monitored and the anesthesiologist avoided sodium 
and fluid overload.11 All patients received 8 mg of intravenous 
dexamethasone and 8 mg of ondansetron as prophylaxis to 
avoid any postoperative nausea and vomiting.
Postoperative pain was managed with a combination of 
intravenous patient-controlled analgesics (PCA, contained 
fentanyl citrate [15 mcg/kg] and ondansetron hydrochloride 
dehydrate [16 mg] with normal saline in 100 mL of total 
volume) and nonsteroidal anti-inflammatory drug (NSAID), 
50 mg flurbiprofen axetil.12 Additional analgesics were 
administered only when the patient complained about pain. 
If additional pain control was required, demerol 25 mg was 
intravenously injected. Oral feeding was initiated at day 1 
after surgery, following a stepwise program. On the first 
POD, patients were allowed to drink water. On the second 
POD, a clear liquid diet was given unless patients had a high 
temperature (38.5°C or higher). A full liquid diet was started 
on POD 3. The patients began to eat solid food on POD 4, 
starting with rice gruel and soft food. During the first 1–4 
days intravenous infusion of fat emulsion, amino acids, and 
glucose was administered according to daily physiological 
need, postoperatively.13 Urinary catheters were removed at 6 
hours after the surgery when patients were fully conscious.14 
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Drains were not routinely used and in the cases they were 
used, tubes were removed on the second or third POD if the 
drainage fluid was clear and the amount of drainage discharge 
was less than 100 mL/day.14 Patients were encouraged to sit 
out of bed for more than 6 hours on the day of surgery and 
ambulation was encouraged on the evening of the day of 
surgery. All patients were mobilized on the POD 1.15
Conventional perioperative care
Patients in the conventional surgery group received conven-
tional perioperative care. The traditional radical gastrectomy 
perioperative procedure: 1) fasting for 10 hours prior to 
surgery and stopping fluid intake 6 hours prior to surgery, 2) 
bowel preparation (enemas and oral antibiotics), 3) nasogastric 
tube and peritoneal drainage tube placement, 4) administra-
tion of general anesthesia, 5) resumption of diet after the first 
flatus, and 6) resumption of ambulation 2–3 days after surgery.
Patients in the traditional perioperative care group were 
allowed to have a liquid diet until lunch of the day before 
surgery and after dinner no further food intake was allowed. 
Intensive bowel preparation (10 mL 0.75% sodium picosul-
fate hydrate and 34 g magnesium citrate) was administered 
the day before surgery. The operation was carried out under 
general anesthesia with endotracheal intubation. Anesthesia 
was general anesthesia without combination of local pre-
emptive analgesia. Postoperative pain was managed by PCA 
only. The use of PCA was similar to that of the conventional 
care (CC) group. NSAIDs were not routinely used in the 
CC group. Additional painkillers were not routinely given 
and additional analgesics were administered only when the 
patient complained about pain. Nasogastric tube was used 
for stomach decompression before surgery and removed after 
the bowel function recovered completely.
Postoperative treatment consisted of parenteral nutrition 
of fat emulsion, amino acids and glucose (11%) injection, 
which was administered until flatus. At that time, the nasogas-
tric tube was removed and the patients were advised to drink 
water. After full intestinal recovery, the diet consisted of a 
clear liquid diet, then a full liquid diet, and finally a soft diet 
(Table 1). The patients received nutritional support of 0.20 
g/kg/day nitrogen and 25–30 kcal/kg/day calories. In the CC 
group, the urinary catheters were removed at 2–3 day after 
surgery. Drains routinely were used and the drainage tubes 
were removed on POD 5 or 6 if the drainage fluid was clear 
and the amount of drainage discharge was less than 100 mL/
day. Ambulation was encouraged 24 hours after surgery in 
this group and all patients were mobilized on the POD 1–2 
in CC group.
Discharge criteria
Patients were discharged based on the following criteria: 1) 
normal body temperature; 2) adequate pain control with oral 
medication; 3) absence of nausea and/or vomiting; 4) good 
flatus and/or defecation; 5) ability to tolerate non-elemental 
diet and soft food without intravenous nutritional support; 
6) mobilization without assistance; 7) normal laboratory 
data; 8) no postoperative complications; and 9) acceptance 
of discharge by the patient.
Follow-up
In the ERAS group the patients kept in touch with us by an 
outpatient service or telephone after discharge within the first 
24 hours and once weekly for 4 weeks. The patients could 
also contact us if they had any discomfort. Readmission was 
considered if any of the following occurred: hyperpyrexia, 
abdominal pain, bowel obstruction, gastrointestinal hemor-
rhage, infection or poor healing of the wound.
statistical analysis
Comparisons between the study groups were performed using 
Student’s t-test, Chi-squared test, Mann–Whitney U test, or 
Fisher’s exact test as appropriate. Continuous variables are 
represented as the mean ± standard deviation (SD) and were 
Table 1 Comparison of clinicopathologic characteristics between 
the eRas and CC groups
Characteristics ERAS group 
(n=102)
CC group 
(n=264)
P-value
age
≤60
>60
Mean
Median
Years
gender
Male
Female
BMi (kg/m2)
nRs 2002 score
1
2
asa score
i
ii
TNM classification
i
ii
iii
54
48
58
57
34–79
62
40
22.18±3.55
40
62
58
44
39
32
31
145
119
58
56
37–79
133
131
21.81±3.20
101
163
74
90
105
87
72
0.733
0.074
0.338
0.866
0.107
0.837
Abbreviations: eRas, enhanced recovery after surgery; CC, conventional care; 
asa, american society of anesthesiologists; BMi, body mass index; nRs, nutritional 
risk screening; TnM, tumor node metastasis.
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analyzed using Student’s t-test or Mann–Whitney U-test. 
Categorical variables are presented as counts and percentages 
and were analyzed using the Chi-squared test or the Fisher’s 
exact test. All statistical tests were two-tailed, and a value of 
P<0.05 was considered statistically significant. All statistical 
analyses were performed using SPSS 17.0 statistics software 
(SPSS Inc., Chicago, IL, USA).
Patient characteristics
A total of 366 patients were included in the study, 171 females 
and 195 males, with a mean age of 57.93 years (57.93±10.69 
years) and mean body mass index of 21.91 kg/m2 (range: 
14.38–30.86 kg/m2) (Table 1). There were 232 patients 
(63.39%) in ASA class I and 134 patients (36.61%) in ASA 
class II. The procedures performed were total gastrectomy in 
162 patients (44.26%) and distal gastrectomy in 204 patients 
(55.74%). Digestive continuity was restored by a Billroth I 
gastroduodenostomy or Billroth II gastrojejunostomy after 
partial gastrectomy, and a Roux-en-Y jejunal loop after 
total gastrectomy (esophagojejunostomy). Evaluation of 
tumor stages revealed 144 (39.34%) patients at stage I, 119 
(32.51%) patients at stage II, and 103 (28.14%) patients at 
stage III. The ERAS group comprised 102 patients includ-
ing 53 patients undergoing laparoscopic gastrectomy and 49 
patients undergoing open surgery with routine use of ERAS 
protocol. The CC group comprised 264 patients including 
128 patients undergoing laparoscopic gastrectomy and 136 
patients undergoing open surgery with conventional care.
Clinicopathological features with 
malnourishment
Clinicopathological features
After statistical analysis, we found that there were no signifi-
cant differences between the ERAS group and the CC group 
in terms of age (P=0.733), gender (P=0.074), BMI (P=0.338), 
NRS 2002 score (P=0.866), ASA score (P=0.107) and TNM 
classification (P=0.837) (Table 1).
surgical procedures and outcomes
Operation time
Operation time was statistically associated with the ERAS 
and CC groups (P=0.007) (Table 2). The mean time used to 
complete the surgery in the ERAS group was 186.00±43.03 
and 169.20±56.54 minutes in the CC group.
intraoperative blood loss
There was no statistical significance in intraoperative blood 
loss between the ERAS and CC groups (P=0.3406) (Table 2). 
On the other hand, the median amount of bleeding was 
less in the laparoscopic surgery patients than in the open 
surgery patients in the ERAS and CC groups, respectively 
(114.58±19.5 mL vs 162.50±32.9 mL, 107.65±42.49 mL 
vs 147.06±39.80 mL). The difference was not statistically 
significant (P>0.05).
Comparison of postoperative recovery
gastrointestinal function recovery
Compared with the CC group, the patients in the ERAS group 
showed significantly accelerated recovery of gastrointestinal 
function in terms of time to first flatus (P<0.001) (Table 3). 
The mean time to first flatus was 3.26±0.64 postoperative 
days in the ERAS group and 4.68±0.49 postoperative days 
in the CC group. In subgroup analysis, first flatus in patients 
undergoing laparoscopic surgery was earlier than patients 
undergoing open surgery in the CC group, but the difference 
was not statistically significant (4.65±0.51 vs 4.71±0.47 
post-operative days), (P=0.3439). Compared with patients 
undergoing laparoscopic surgery in the ERAS group, the 
duration of first flatus was similar to those patients receiving 
open surgery (3.17±0.67 vs 3.35±0.60 postoperative days), 
(P=0.1637). There was no statistical significance between the 
patients undergoing Billroth I, Billroth II, Roux-en-Y and 
between patients who received partial or total gastrectomies 
in the meantime to first flatus in the CC group or in the ERAS 
group, respectively.
Pain control
VAS analysis showed that pain intensity of patients in the 
ERAS group was significantly lower than that of patients 
in the CC group on postoperative days 1 and 2 (P<0.05) 
Table 2 Comparison of surgical procedures and outcomes 
between the eRas and CC groups
Characteristics ERAS group 
(n=102)
CC group  
(n=264)
P-value
surgical approach
laparoscopic assisted 53 128 0.551
Open 49 136
Type of operation
Distal gastrectomy 58 146 0.788
Total gastrectomy 44 118
Type of reconstruction
Billroth i 27 55
Billroth ii 31 91 0.484
Roux-en-Y 44 118
Operation time 
(minutes)
186.00±43.03 169.20±56.54 0.007a
Blood loss 142.6±45.27 147.3±41.05 0.341
Note: aStatistically significant (P<0.05).
Abbreviations: eRas, enhanced recovery after surgery; CC, conventional care.
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(Table 3). Additional pain control was more frequently needed 
in the CC group than in the ERAS group.
Postoperative surgical stress and inflammatory 
response
The response induced by systemic surgical stress was 
assessed by measuring the white blood cell (WBC) count and 
C-reactive protein levels. When comparing the WBC count 
before surgery between the groups, there was no statistical 
significance (P=0.223) (Table 4). The WBC count in both 
groups was elevated on POD 1 but compared to ERAS group 
on POD 1 the WBC in the CC group was significantly lower 
(P<0.025); however the WBC count in the ERAS group began 
to drop on POD 3 while the WBC count in the CC group 
continued to rise (P<0.01).
For the inflammatory marker C-reactive protein, there was 
no statistical significance between the ERAS and CC groups 
before surgery (P=0.289) (Table 4). There was statistical sig-
nificance for C-reactive protein on POD 1 (P<0.01) (Table 4). 
The median CRP (range) level increased from 22.07±6.70 mg/
dL to 57.77±15.88 mg/dL at day 3 after surgery in the ERAS 
group and from 23.96±6.76 mg/dL to 61.50±16.30 mg/dL at 
day three after surgery in the conventional perioperative care 
group. Furthermore, compared with the conventional perioper-
ative care group, the level of CRP in the ERAS group was also 
lower on POD 3 (P=0.049). Similarly, the median lymphocyte 
count (range) decreased from 1.83±0.53 to 2.20±0.73 in the 
ERAS group and from 1.35±0.59 to 1.50±0.72 in the CC group 
at POD 3, which was also statistically significant (P<0.01).
nutritional status
The postoperative nutritional status was assessed by mea-
suring albumin serum concentrations and total lymphocyte 
count. There was no statistical significance between the 
Table 3 Comparison of postoperative clinical outcomes between 
eRas and CC groups
Characteristics ERAS group 
(n=102)
CC group 
(n=264)
P-value
Time to first flatus (h)
Vas POD 1
Vas POD 2
number of additional doses of 
analgesics
Postoperative hospital stays 
(days)
Postoperative death
Readmissions (n)
3.26±0.64
2.33±0.98
1.06±0.63
2(1.96%)
6.66±3.36
0
4 (3.92%)
4.68±0.49
4.17±0.99
2.35±0.71
20(7.58%)
9.02±2.61
0
14 (5.30%)
<0.001a
<0.001a
<0.001a
0.043a
<0.001a
0.584
Notes: The values given are number of patients unless indicated otherwise. 
aStatistically significant (P<0.05).
Abbreviations: eRas, enhanced recovery after surgery; CC, conventional care; 
POD, postoperative day; Vas, visual analog scale.
Table 4 Comparison of laboratory findings between the ERAS 
and CC groups
Characteristics ERAS group 
(n=102)
CC group 
(n=264)
P-value
White blood cell count
Before surgery
POD 1
POD 3
albumin (g/l)
Before surgery
POD 1
POD 3
lymphocyte count
Before surgery
POD 1
POD 3
CRP (mg/dl)
Before surgery
POD 1
POD 3
Postoperative hospital 
stays (days)
6.36±1.58
12.03±1.46
10.30±2.23
40.05±2.54
28.63±2.27
27.67±2.76
2.52±0.45
1.83±0.53
2.20±0.73
5.05±0.51
22.07±6.70
57.77±15.88
5.56±0.50
6.58±1.48
12.44±1.62
12.61±2.37
39.82±2.58
26.11±1.82
25.63±2.05
2.44±0.49
1.35±0.59
1.50±0.72
5.11±0.49
23.96±6.76
61.50±16.30
7.94±0.75
0.223
0.025a
<0.01a
0.441
<0.01a
<0.01a
0.180
<0.01a
<0.01a
0.289
0.017a
0.049a
<0.001a
Note: aStatistically significant (P<0.05).
Abbreviations: eRas, enhanced recovery after surgery; CC, conventional care; 
CRP, C-reactive protein; POD, postoperative day.
groups before surgery (P=0.441) (Table 4). The median 
albumin (range) level decreased from 28.63±2.27 mg/dL to 
27.67±2.76 mg/dL in the ERAS group and from 26.11±1.82 
mg/dL to 25.63±2.05 mg/dL in the CC group at POD 3, which 
was statistically significant (P<0.01).
Postoperative hospital stays
Postoperative hospital stays were significantly shorter in 
patients receiving ERAS treatment than in those patients 
who received conventional perioperative care 6.66±3.36 vs 
9.02±2.61 days; P<0.001) (Table 4).
Postoperative complications
No statistical significance was found between the incidences 
of postoperative complications in the ERAS and CC groups 
(P=0.915) (Table 5). A total of 15 (14.71%) patients experi-
enced postoperative complications in the ERAS group and 
40 (15.15%) patients in the CC group developed postopera-
tive complications (Table 5). The operative complications 
were anastomotic leakage (n=8; P=0.855), intra-abdominal 
infection (n=7; P=0.418), surgical incision infection (n=12; 
P=0.379), incision fat liquefaction (n=18; P=0.993), and 
gastroparesis (n=9; P=0.061).
The 30-day mortality and readmission rate
No deaths occurred within the first 30 days after surgery in 
either group (Table 3). No significant differences in 30-day 
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readmission rates were recorded between the ERAS group 
with three patients (2.94%) readmitted compared to five 
patients (1.89%) in the CC group (P=0.539, Table 3). The 
main reasons for readmission were anastomotic leakage, 
infection and intestinal obstruction.
Discussion
In the present study, we demonstrated the effectiveness and 
feasibility of our ERAS program in gastric cancer patients 
who underwent radical gastrectomy (distal subtotal, proximal 
subtotal, or radical total gastrectomy) by open surgery or 
laparoscopy. Compared with the conventional periopera-
tive care group, the ERAS group had a faster postoperative 
bowel recovery (P<0.001), patients experienced lesser pain 
(P<0.001) and had a shorter postoperative hospitalization 
time (P<0.001). How to effectively reduce the perioperative 
stress response and accelerate the postoperative recovery 
has become a key point in the field of gastric surgery. The 
trauma and stress that patients suffer are not only because 
of the surgery itself, but also come from anxiety, tension, 
pain, hypothermia, hypoxia, hunger, nausea, vomiting, sleep 
disorders, a variety of drainage tubes, catheter placement 
and movement disorder. All these factors could cause organ 
dysfunction and ultimately affect the wound healing and 
postoperative rehabilitation.16
ERAS encompassed a combination of preoperative, 
intraoperative and postoperative measures to enhance the 
postoperative recovery in surgical procedures. Compared 
with conventional care, ERAS could reduce the stress 
response and organ dysfunction, shorten the duration to flatus 
and defecation, accelerate the decrease in CRP and WBC, 
and thereby greatly shorten the postoperative stay, fasten the 
recovery of gut function, shorten the time required for overall 
recovery and increase patients’ satisfaction.4,7,17,18 Our results 
were consistent with the findings of other  studies.2,4 We found 
that in our study ERAS was able to reduce postoperative 
Table 5 Comparison of postoperative complications between 
the eRas group and CC groups
Characteristics ERAS group 
(n=102)
CC group 
(n=264)
P-value
Postoperative complications
anastomotic leakage
intra-abdominal infection
surgical-incision infection
incision fat liquefaction
gastroparesis
15 (14.71%)
2 (1.96%)
1 (0.98%)
2 (1.96%)
5 (4.90%)
5 (4.90%)
40 (15.15%)
6 (2.27%)
6 (2.27%)
10 (3.79%)
13 (4.92%)
4 (1.52%)
0.915
0.855
0.418
0.379
0.993
0.061
Abbreviations: eRas, enhanced recovery after surgery; CC, conventional care.
stress and inflammation (P<0.001). ERAS aims to improve 
outcomes and promote early discharge by emphasizing 
preoperative patient education, shortening the duration of 
preoperative fasting, supplying preoperative carbohydrates, 
no bowel preparation, active prevention of hypothermia, no 
routine use of nasogastric tubes, controlling pain sufficiently 
without opioids, providing early ambulation, and quickly 
advancing the return to a normal diet. Studies have found 
that some procedures in gastrectomy for example routine 
nasogastric decompression were unnecessary because early 
oral feeding enhances the postoperative gastrointestinal tract 
recovery and decreased the duration of hospital stay without 
increasing complications.20 In the present study we found that 
patients after gastrectomy in the ERAS group had a shorter 
hospital stay (P<0.001) and postoperative complications had 
no statistical significance (P=0.915).
Preoperative patient education through contact between 
patients and staff can avoid the anxiety and perioperative 
stress reactions, which promotes faster recovery. Optimal 
pain control plays a fundamental role in postoperative care. 
Postoperative pain is one of the most important factors that 
delays postoperative recovery by not only increasing surgi-
cal stress, but also affecting the mobilization of patients.21,22 
The results showed that pain intensity in the ERAS group 
was significantly lower than that of the CC group (P<0.001). 
Usage of analgesics was significantly less in the ERAS group. 
Wang et al7 reported that the first day of flatus after gastrec-
tomy was faster in patients who received ERAS care than in 
those who received conventional care. Our result is similar 
to his findings (P<0.001), times to first flatus in the ERAS 
group were 3.26±0.64 days and 4.68±0.49 days in the CC 
group. Prolonged perioperative fasting, preoperative bowel 
preparation, and nasogastric tube intubation were likely to 
delay bowel-function recovery. Previous studies have shown 
that the small intestine might return to normal enterocine-
sia 6 hours after abdominal surgery, and that liquid can be 
easily absorbed in the small intestine in early postoperative 
recovery.23
Early oral feeding was safe.17,21 Early postoperative 
enteral nutrition with dietary fiber could accelerate recovery 
of peristalsis, protect gut mucosal barrier function, alleviate 
intestinal barrier dysfunction, decrease incidence of bacterial 
translocation and enhance the recovery of gut function.24 In 
the present study, most patients who underwent ERAS toler-
ated early oral diet well. Although gastroparesis occurred in 
some patients, the symptoms mostly occurred in the initial 
stage of oral diet and did not develop into severe complica-
tions (P=0.061). Several studies showed that ERAS resulted 
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in significantly reduced postoperative hospital stays for gas-
trectomy.7 It was reported that the postoperative hospital stay 
in gastric cancer patients could be decreased to 3.8 days in 
the ERAS group.25 In the present study, ERAS patients had 
a mean postoperative hospital stay of 6.66±3.36 days and 
9.02±2.61 days in the CC group. The results of our study 
suggested that postoperative recovery was significantly 
enhanced by our ERAS protocol in gastric cancer patients 
undergoing gastrectomy.
Conclusion
ERAS can reduce postoperative stress, enhance the recovery 
of the gut, reduce pain intensity, shorten hospital stays and 
increase satisfaction in gastric cancer patients undergoing 
curative gastrectomy.
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